MCP-1 inhibitors (Angelini Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMCP-1 inhibitors (Angelini Pharmaceuticals)
Drug Alias NameCCL-2 inhibitors (Angelini Pharmaceuticals)cytokine production inhibitors (Angelini Pharmaceuticals)AF-11AF-13AF-6
ClassificationSmall molecules
Mechanisms of ActionC-C motif chemokine 2 inhibitorsCytokine synthesis inhibitors
TargetsC-C motif chemokine 2
Therapy Area/IndicationsPainInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngelini Pharma SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngelini Pharma SPA
Active IndicationsN/A
Inactive IndicationsPainInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A